BACKGROUND: Major depressive disorder (MDD) is inconsistently associated with elevations in proinflammatory cytokines and neuropeptides. We used a skin sweat patch, recently validated in healthy control subjects, and recycling immunoaffinity chromatography to measure neuroimmune biomarkers in patients with MDD mostly in remission. METHODS: We collected blood at 8:00 am and applied skin sweat patches for 24 hours in 21- to 45-year-old premenopausal women (n = 19) with MDD (17/19 in remission) and age-matched healthy controls (n = 17) participating in the POWER (Premenopausal, Osteopenia/Osteoporosis, Women, Alendronate, Depression) Study. RESULTS: Proinflammatory cytokines, neuropeptide Y, substance P, and calcitonin-gene-related peptide were significantly higher and vasoactive intestinal peptide, a marker of parasympathetic activity, was significantly lower in patients compared to controls, and depressive symptomatology strongly correlated with biomarker levels. All analytes were strongly correlated in the skin sweat patch and plasma in patients (r = .73 to .99; p < .0004). CONCLUSIONS: The skin sweat patch allows detection of disrupted patterns of proinflammatory cytokines and neuropeptides in women with MDD in clinical remission, which could predispose to medical consequences such as cardiovascular disease, osteoporosis, and diabetes. This method permits measurement of cytokines in ambulatory settings where blood collection is not feasible.
BACKGROUND:Major depressive disorder (MDD) is inconsistently associated with elevations in proinflammatory cytokines and neuropeptides. We used a skin sweat patch, recently validated in healthy control subjects, and recycling immunoaffinity chromatography to measure neuroimmune biomarkers in patients with MDD mostly in remission. METHODS: We collected blood at 8:00 am and applied skin sweat patches for 24 hours in 21- to 45-year-old premenopausal women (n = 19) with MDD (17/19 in remission) and age-matched healthy controls (n = 17) participating in the POWER (Premenopausal, Osteopenia/Osteoporosis, Women, Alendronate, Depression) Study. RESULTS: Proinflammatory cytokines, neuropeptide Y, substance P, and calcitonin-gene-related peptide were significantly higher and vasoactive intestinal peptide, a marker of parasympathetic activity, was significantly lower in patients compared to controls, and depressive symptomatology strongly correlated with biomarker levels. All analytes were strongly correlated in the skin sweat patch and plasma in patients (r = .73 to .99; p < .0004). CONCLUSIONS: The skin sweat patch allows detection of disrupted patterns of proinflammatory cytokines and neuropeptides in women with MDD in clinical remission, which could predispose to medical consequences such as cardiovascular disease, osteoporosis, and diabetes. This method permits measurement of cytokines in ambulatory settings where blood collection is not feasible.
Authors: M Sarno; L Sarno; D Baylink; B Drinkwater; S Farley; M Kleerekoper; R Lang; J Lappe; A Licata; M McClung; P Miller; S Nattrass; R Recker; E N Schwartz; J R Tucci; S Wolf; H Powell; G Tjersland; G R Warnick Journal: Clin Chem Lab Med Date: 2001-03 Impact factor: 3.694
Authors: Philip E Castle; Terry M Phillips; Allan Hildesheim; Rolando Herrero; M Concepcion Bratti; Ana Cecilia Rodríguez; Lidia Ana Morera; Ruth Pfeiffer; Martha L Hutchinson; Ligia A Pinto; Mark Schiffman Journal: Cancer Epidemiol Biomarkers Prev Date: 2003-12 Impact factor: 4.254
Authors: Jill M Hartman; Ann Berger; Karen Baker; Jacques Bolle; Daniel Handel; Andrew Mannes; Donna Pereira; Diane St Germain; Donna Ronsaville; Nina Sonbolian; Sara Torvik; Karim A Calis; Terry M Phillips; Giovanni Cizza Journal: Health Qual Life Outcomes Date: 2006-01-18 Impact factor: 3.186
Authors: Olivier Lesouhaitier; Thomas Clamens; Thibaut Rosay; Florie Desriac; Mélissande Louis; Sophie Rodrigues; Andrei Gannesen; Vladimir K Plakunov; Emeline Bouffartigues; Ali Tahrioui; Alexis Bazire; Alain Dufour; Pierre Cornelis; Sylvie Chevalier; Marc G J Feuilloley Journal: J Innate Immun Date: 2018-11-05 Impact factor: 7.349
Authors: C J Crandall; D Miller-Martinez; G A Greendale; N Binkley; T E Seeman; A S Karlamangla Journal: Osteoporos Int Date: 2011-08-03 Impact factor: 4.507
Authors: Z Sonner; E Wilder; J Heikenfeld; G Kasting; F Beyette; D Swaile; F Sherman; J Joyce; J Hagen; N Kelley-Loughnane; R Naik Journal: Biomicrofluidics Date: 2015-05-15 Impact factor: 2.800
Authors: Jason Heikenfeld; Andrew Jajack; Benjamin Feldman; Steve W Granger; Supriya Gaitonde; Gavi Begtrup; Benjamin A Katchman Journal: Nat Biotechnol Date: 2019-02-25 Impact factor: 54.908
Authors: Carolyn A Fredericks; Emily M Drabant; Michael D Edge; Jean M Tillie; Joachim Hallmayer; Wiveka Ramel; Janice R Kuo; Sean Mackey; James J Gross; Firdaus S Dhabhar Journal: Brain Behav Immun Date: 2009-10-31 Impact factor: 7.217
Authors: Steve H Faulkner; Kate L Spilsbury; James Harvey; Andrew Jackson; Jingfeng Huang; Mark Platt; Alfred Tok; Myra A Nimmo Journal: Eur J Appl Physiol Date: 2014-03-01 Impact factor: 3.078